Immunocore Holdings Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Immunocore Holdings Ltd - ADR
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
/ 
Frequently asked questions
To buy Immunocore Holdings Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Immunocore Holdings Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Immunocore Holdings Ltd - ADR is IMCR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Immunocore Holdings Ltd - ADR has its primary listing on NASDAQ. You can trade Immunocore Holdings Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Immunocore Holdings Ltd - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Immunocore Holdings Ltd - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Immunocore Holdings Ltd - ADR.